[1] P SINGAL, M LI T, D KUMAR et al. Adriamycin-induced heart failure: mechanisms and modulation. Mol. Cell. Biochem., 207, 77-86(2000).
[2] P GILLET J, M GOTTESMAN M. Mechanisms of multidrug resistance in cancer. Methods. Mol. Biol., 596, 47-76(2010).
[3] A PERSIDIS. Cancer multidrug resistance. Nat. Biotechnol., 17, 94-95(1999).
[4] D PEER, M KARP J, S HONG et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotech., 2, 751-760(2007).
[5] V MALTZAHM G, H PARK J, Y LIN K et al. Nanoparticles that communicate
[6] E ASHLEY C, C CARNES E, K PHILLIPS G et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater., 10, 389-397(2011).
[7] Y CHEN, C TAN, H ZHANG et al. Two-dimensional graphene analogues for biomedical applications. Chem. Soc. Rev., 44, 2681-2701(2015).
[8] D CHIMENE, L ALGE D, K GAHARWAR A. Two-dimensional nanomaterials for biomedical applications: emerging trends and future prospects. Adv. Mater., 27, 7261-7284(2015).
[9] J WU, J ZHU Y, F CHEN. Ultrathin calcium silicate hydrate nanosheets with large specific surface areas: synthesis, crystallization, layered self-assembly and applications as excellent adsorbents for drug, protein, and metal ions. Small, 9, 2911-2925(2013).
[10] C EISENBARTH S, R COLEGIO O, W O C JR et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature, 453, 1122-1126(2008).
[11] L FLACH T, G NG, A HARI et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat. Med., 17, 479-487(2011).
[12] T MARICHAL, K OHATA, D BEDORET et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med., 17, 996-1002(2011).
[13] X LI, P WANG X, A ITO. Tailoring inorganic nanoadjuvants towards next-generation vaccines. Chem. Soc. Rev., 47, 4954-4980(2018).
[14] B SUN, Z JI, P LIAO Y et al. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. ACS Nano., 7, 10834-10849(2013).
[15] W CAI, J YU, S MANN. Template-free hydrothermal fabrication of hierarchically organized
[16] G LI, L GUAN, Y LIU et al. Template-free solvothermal synthesis of 3D hierarchical nanostructured boehmite assembled by nanosheets. J. Phys. Chem. Solids., 73, 1055-1060(2012).
[17] P WANG X, X LI, Y SOGO et al. Simple synthesis route of mesoporous AlOOH nanofibers to enhance immune responses. RSC. Adv., 3, 8164-8167(2013).
[18] R WEN J, H LIU M, Y MOU C. Synthesis of curtain-like crumpled boehmite and
[19] W HICKS R, J PINNAVAIA T. Nanoparticle assembly of mesoporous AlOOH (Boehmite). Chem. Mater., 15, 78-82(2003).
[20] X LI, X WANG, Z HUA et al. One-pot synthesis of magnetic and mesoporous bioactive glass composites and their sustained drug release property. Acta. Mater., 56, 3260-3265(2008).
[21] A BARRETO J, W O’MALLEY, M KUBEIL et al. Nanomaterials: applications in cancer imaging and therapy. Adv. Mater., 23, H18-H40(2011).
[22] L BILDSTEIN, C DUBERNET, P COUVREUR. Prodrug-based intracellular delivery of anticancer agents. Adv. Drug. Delivery. Rev., 63, 3-23(2011).
[23] T SKOVSGAARD, I NISSEN N. Membrane transport of anthracyclines. Pharmacol. Therapeut., 18, 293-311(1982).
[24] X LI, X WANG, Y SOGO et al. Mesoporous silica-calcium phosphate- tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy. Adv. Healthcare. Mater., 2, 863-871(2013).
[25] D BLOEBAUM R, A LUNDEEN G, N BACHUS K et al. Dissolution of particulate hydroxyapaptite in a macrophage organelle model. J. Biomed. Mater. Res., 40, 104-114(1998).
